SciELO - Scientific Electronic Library Online

vol.20 issue2Perfiles genéticos (RFLP-IS6110) y resistencia a drogas en aislamientos de M. tuberculosis de pacientes internados en un hospital referencial del Callao, Perú author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Peruana de Medicina Experimental y Salud Publica

Print version ISSN 1726-4634


CALDERON E, Róger et al. Detección rápida de resistencia a drogas en Mycobacterium tuberculosis mediante PCR-SSCP y PCR- Heteroduplex. Rev. perú. med. exp. salud publica [online]. 2003, vol.20, n.2, pp.65-71. ISSN 1726-4634.

Objective: Early detection of Mycobacterium tuberculosis susceptibility to two anti tuberculous drugs,rifampin and isoniazid using PCR and conformational electrophoresis. Material and methods: Two amplification assays were implemented for the rpoB and katG genes and susceptibility to antituberculous agents was determined by heteroduplex and SSCP in 31clinical samples obtained from patients with positive smear pulmonar tuberculosis.The phenotypical characterization of susceptibility to antituberculous agents was performed using proportion method. Results: PCR assays detected up to 2,5 pg of M. tuberculosis genomic DNA, no amplifications of DNA of other mycobacteria and common bacteria of buccal flora was performed. The general concordance between the molecular and conventional detection of rifampin and isoniazid susceptibility was 96,7% and 83,9% (p<005) respectively. However, a 100% and 90,9% concordance (p<0,05) for rifampin and isoniazid respectively was found only in patients who received previous treatment. Moreover, this resistance detection system can give results 48 hours after the clinical sample is obtained. Conclusion: These systems showed to be an excellent diagnosis alternative for the early identification of patients infected with drugresistant Mycobacterium tuberculosis. It will potentially allow the use of timely and optimal treatment schemes that may contribute to the control and prevention of multidrug-resistant strains that affect public health in our country.

Keywords : PCR; Heteroduplex; SSCP; Tuberculosis; Resistance; Rifampin; Isoniazid.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License